Table 2a.
Participant characteristics | Total | SARS-CoV-2 seropositive participants | |||
---|---|---|---|---|---|
N | n | % (95% CI) | p-value* | ||
All participants | 5,085 | 898 | 18 (17–19) | ||
Hospital | Hospital 1 | 2,945 | 623 | 21 (20–23) | <0.001 |
Hospital 2 | 2,140 | 275 | 13 (11–14) | ||
Age groups (years) | 18–29 | 1,108 | 249 | 22 (20–25) | <0.001 |
30–39 | 1,330 | 238 | 18 (16–20) | ||
40–49 | 1,414 | 208 | 15 (13–17) | ||
50–59 | 951 | 158 | 17 (14–19) | ||
Over 60 | 282 | 45 | 16 (12–21) | ||
Sex | Female | 3,959 | 669 | 17 (16–18) | 0.008 |
Male | 1,126 | 229 | 20 (18–23) | ||
Ethnicity | Irish (White) | 3,798 | 595 | 16 (15–17) | <0.001 |
Any other white background | 476 | 94 | 20 (16–24) | ||
Asian background | 599 | 148 | 25 (21–28) | ||
African or any other black background | 117 | 39 | 33 (25–43) | ||
Other | 95 | 22 | 23 (15–33) | ||
Country of birth | Ireland | 3,630 | 567 | 16 (14–17) | <0.001 |
United Kingdom | 295 | 44 | 15 (11–20) | ||
India | 293 | 76 | 26 (21–31) | ||
Philippines | 214 | 54 | 25 (20–32) | ||
Poland | 85 | 20 | 24 (15–34) | ||
USA | 55 | 11 | 20 (10–33) | ||
Romania | 45 | 15 | 33 (20–49) | ||
Nigeria | 35 | 19 | 54 (31–71) | ||
Other | 433 | 92 | 21 (17–25) | ||
Education | Primary | 22 | 7 | 32 (14–55) | <0.001 |
Secondary | 609 | 133 | 22 (19–25) | ||
Third level | 2,244 | 434 | 19 (18–21) | ||
Post-graduate | 2,210 | 324 | 15 (13–16) | ||
Role | Admin | 676 | 85 | 13 (10–15) | <0.001 |
Medical/dental | 713 | 116 | 16 (14–19) | ||
Nursing/ midwifery | 1,891 | 395 | 21 (19–23) | ||
Allied health | 1,044 | 118 | 11 (9.4–13) | ||
General support | 365 | 81 | 22 (18–27) | ||
Health care assistant | 291 | 93 | 32 (27–38) | ||
Other | 105 | 10 | 10 (4.7–17) | ||
Lives with | Alone | 464 | 61 | 13 (10–17) | 0.008 |
With others | 4,610 | 834 | 18 (17–19) | ||
Missing | 11 | 3 | 27 (6.0–61) | ||
Lives with HCW | Yes | 1,571 | 340 | 22 (20–24) | <0.001 |
No | 3,412 | 540 | 16 (16–17) | ||
Missing | 102 | 18 | 18 (11–26) |
Calculated using the chi-square test. Statistically significant findings in bold.